New Jersey Assembly Bill A2789

New Jersey 2022-2023 Regular Session

• Introduced: 2/28/22
• Refer: 2/28/22

Caption

Requires hospital, bio-analytical, and clinical laboratories to provide information and offer of HIV screening to patients living in areas with high prevalence of HIV.

Impact

If passed, the bill is anticipated to significantly influence public health protocols by formalizing procedures for informed consent and communication regarding HIV. By requiring that each individual in high prevalence areas receives critical information about HIV screening, the potential exists for a measurable increase in the number of individuals undergoing testing and, consequently, early identification and treatment of HIV cases. The law stipulates that diagnosed cases will be reported confidentially to the Department of Health, aligning with existing legal frameworks protecting patient information.

Summary

Assembly Bill A2789 focuses on enhancing HIV screening processes within hospitals, bio-analytical, and clinical laboratories specifically targeting individuals residing in areas with high prevalence of HIV. The legislation mandates the distribution of both verbal and written statements outlining the Centers for Disease Control and Prevention (CDC) policy on HIV, along with the offer of an HIV screening test at the time of registration for laboratory services. This initiative aims to ensure that individuals are adequately informed of available screenings, thereby promoting greater testing acceptance and awareness.

Contention

Despite its potential benefits, the bill may provoke debate among stakeholders regarding the implications of mandating HIV testing offers in high prevalence areas. Critics may express concern over the adequacy of resources to support the expected increase in screenings and follow-up care. Furthermore, certain healthcare professionals might question whether such mandates encroach on their discretion related to patient care priorities, particularly in resource-limited settings. Stakeholder discussions will likely center on balancing public health objectives with individual healthcare provider autonomy.